10.1167/iovs.62.3.38 190 UzunogluS.KaragolH.OzpuyanF.CosarR.CicinI.YurutcalogluV.et al (2011)
The aims of this review are (1) to provide an overview of the clinical and biological overlap between neuropsychiatric long COVID and other fatigue-associated neuropsychiatric disorders, (2) to examine the shared molecular mechanisms of fatigue and depressive symptoms involving acetylcarnitine metabolism, and finally (3) to review the current evidence on acetylcarnitine supplementation studies as a treatment for fatigue-associated syndromes and pharmacological aspects of acetylcarnitine supplementation to provide a conceptual foundation for acetylcarnitine supplementation in neuropsychiatric long COVID syndrome
Add $120.01 more to save 8% off Bundle & Save Discount applies automatically at checkout once your cart subtotal hits the tier
Hertz, P., & Richardson, J
In this study, miR-675 embedded in H19 was expressed in the placenta but suppressed in the embryonic tissues
Contributes to studies on energy balance, linking fat use with overall metabolic health
